POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 53 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,690 | -10.3% | 14,996 | -33.7% | 0.00% | – |
| Q2 2023 | $39,790 | -68.8% | 22,608 | -45.4% | 0.00% | – |
| Q1 2023 | $127,564 | +131.9% | 41,417 | +234.5% | 0.00% | – |
| Q1 2022 | $55,000 | -48.1% | 12,383 | -20.2% | 0.00% | – |
| Q4 2021 | $106,000 | -6.2% | 15,514 | 0.0% | 0.00% | – |
| Q3 2021 | $113,000 | -71.5% | 15,514 | -60.9% | 0.00% | – |
| Q2 2021 | $397,000 | -16.8% | 39,657 | -20.6% | 0.00% | -100.0% |
| Q1 2021 | $477,000 | +113.9% | 49,942 | +145.8% | 0.00% | – |
| Q4 2020 | $223,000 | +23.9% | 20,321 | 0.0% | 0.00% | – |
| Q3 2020 | $180,000 | – | 20,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |